Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| STIM | Neuronetics, Inc. | 2026-04-02 18:58:19 | 1.54 | 0.02 | 1.17 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STIM | 0001227636 | Neuronetics, Inc. | US64131A1051 | 549300T0911ILTTG7P06 | — | Nasdaq | 3841 | Surgical & Medical Instruments & Apparatus | 1231 | DE | 3222 PHOENIXVILLE PIKE | MALVERN | PA | 19355 | UNITED STATES | US | 877-600-7555 | 3222 PHOENIXVILLE PIKE, MALVERN, PA, 19355 | 3222 PHOENIXVILLE PIKE, MALVERN, PA, 19355 | Neuronetics, Inc. | — | 2003 | Keith J. Sullivan | 167 | https://neurostar.com/ | 129,300,000 | 68,994,000 | 69,276,593 | Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. | 2026-04-02 19:19:22 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 129,300,000 | 80,400,000 | 164.4172 | 69,276,593 | 3,462,081 | 5.2604 |
| 2024 | 48,900,000 | -7,600,000 | -13.4513 | 65,814,512 | 36,058,459 | 121.1802 |
| 2023 | 56,500,000 | -11,200,000 | -16.5436 | 29,756,053 | 1,392,633 | 4.91 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| W. Andrew Macan | Chief Compliance Officer, Corporate Secretary, Executive Vice President, General Counsel | 2024 | 450,000 | 45,000 | 512,213 | 52,313 | 0 | 1,059,526 |
| Stephen Furlong | Chief Financial Officer, Executive Vice President | 2024 | 466,100 | 46,610 | 546,000 | 54,184 | 69,285 | 1,182,179 |
| Keith J. Sullivan | Chief Executive Officer, President | 2024 | 728,000 | 0 | 1,503,000 | 169,260 | 30,350 | 2,430,610 |
| Keith J. Sullivan | Chief Executive Officer, President | 2023 | 700,000 | 0 | 1,601,700 | 660,800 | 28,485 | 2,990,985 |
| W. Andrew Macan | Chief Compliance Officer, Corporate Secretary, Executive Vice President, General Counsel | 2023 | 409,400 | 51,175 | 531,000 | 155,572 | 13,556 | 1,160,703 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 658 |
| 2024 | 716 |
| 2023 | 203 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 149,157,000 | 74,890,000 | 71,348,000 |
| Cost Of Revenue | 76,849,000 | 20,729,000 | 19,643,000 |
| Gross Profit | 72,308,000 | 54,161,000 | 51,705,000 |
| Research And Development Expenses | 6,584,000 | 12,771,000 | 9,515,000 |
| General And Administrative Expenses | 49,702,000 | 30,322,000 | 25,426,000 |
| Operating Expenses | 103,744,000 | 88,724,000 | 82,259,000 |
| Operating Income | -31,436,000 | -34,563,000 | -30,554,000 |
| Net Income | -38,998,000 | -43,708,000 | -30,189,000 |
| Earnings Per Share Basic | -0.59 | -1.38 | -1.05 |
| Earnings Per Share Diluted | -0.59 | -1.38 | -1.05 |
| Weighted Average Shares Outstanding Basic | 65,951,000 | 31,734,000 | 28,658,000 |
| Weighted Average Shares Outstanding Diluted | 65,951,000 | 31,734,000 | 28,658,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 28,134,000 | 18,459,000 | 59,677,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 16,469,000 | 23,355,000 | 15,782,000 |
| Inventories | 4,327,000 | 4,248,000 | 8,093,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 3,050,000 | 3,078,000 | 2,514,000 |
| Total Assets Current | 61,551,000 | 58,122,000 | 93,793,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 4,466,000 | 6,242,000 | 2,009,000 |
| Other Assets Non Current | 1,982,000 | 1,923,000 | 4,430,000 |
| Total Assets Non Current | 80,000,000 | 82,781,000 | 22,038,000 |
| Total Assets | 141,551,000 | 140,903,000 | 115,831,000 |
| Accounts Payable | 10,739,000 | 11,077,000 | 4,752,000 |
| Deferred Revenue | 753,000 | 974,000 | 1,620,000 |
| Short Term Debt | — | — | — |
| Other Liabilities Current | 652,000 | 605,000 | 1,053,000 |
| Total Liabilities Current | 30,521,000 | 31,265,000 | 19,812,000 |
| Long Term Debt | 65,807,000 | 55,151,000 | 59,283,000 |
| Other Liabilities Non Current | — | — | — |
| Total Liabilities Non Current | 84,790,000 | 77,839,000 | 61,829,000 |
| Total Liabilities | 115,311,000 | 109,104,000 | 81,641,000 |
| Common Stock | 690,000 | 557,000 | 291,000 |
| Retained Earnings | -458,787,000 | -419,789,000 | -376,081,000 |
| Accumulated Other Comprehensive Income | — | — | — |
| Total Shareholders Equity | 22,378,000 | 27,706,000 | 34,190,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 2,000,000 | 2,100,000 | 2,000,000 |
| Share Based Compensation Expense | 6,848,000 | 5,602,000 | 7,319,000 |
| Other Non Cash Income Expense | -72,000 | -28,000 | — |
| Change In Accounts Receivable | -3,541,000 | 3,727,000 | 8,831,000 |
| Change In Inventories | 395,000 | -3,150,000 | 1,098,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | -1,750,000 | -1,985,000 | 2,029,000 |
| Change In Other Liabilities | 257,000 | -66,000 | -2,243,000 |
| Cash From Operating Activities | -20,374,000 | -30,997,000 | -32,038,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 801,000 | 1,466,000 | 2,369,000 |
| Acquisition Of Business | — | 2,553,000 | — |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -801,000 | -2,413,000 | -1,322,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | 20,700,000 | — | — |
| Repurchase Of Common Stock | — | — | — |
| Issuance Of Long Term Debt | 10,000,000 | 57,479,000 | 25,000,000 |
| Repayment Of Long Term Debt | — | 60,000,000 | 1,200,000 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | 35,850,000 | -6,808,000 | 22,697,000 |
| Change In Cash | 14,675,000 | -40,218,000 | -10,663,000 |
| Cash At End Of Period | 28,134,000 | 18,459,000 | 59,677,000 |
| Income Taxes Paid | — | — | — |
| Interest Paid | 7,591,000 | 6,513,000 | 4,790,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | -0.59 | -1.38 | -1.05 |
| Price To Earnings Ratio | -2.339 | -1.1667 | -2.7619 |
| Earnings Growth Rate | -57.2464 | 31.4286 | -23.913 |
| Price Earnings To Growth Ratio | 0.0409 | -0.0371 | 0.1155 |
| Book Value Per Share | 0.3979 | 1.002 | 1.193 |
| Price To Book Ratio | 3.4685 | 1.6067 | 2.4308 |
| Ebitda | -29,398,000 | -34,322,000 | -22,765,000 |
| Enterprise Value | 128,685,380 | 87,783,740 | 82,714,200 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | 2.9407 | 1.9906 | 1.7339 |
| Capital Expenditures | 224,000 | 6,333,000 | 2,018,000 |
| Free Cash Flow | -20,598,000 | -37,330,000 | -34,056,000 |
| Return On Equity | -1.7427 | -1.5776 | -0.883 |
| One Year Beta | 1.7082 | 1.2471 | 1.3207 |
| Three Year Beta | 1.5123 | 1.2372 | 1.2517 |
| Five Year Beta | 1.3701 | 1.3038 | 1.2956 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Chernett Jorey | 10% owner | 2026-03-30 | 385,442 | A | 9,778,988 |
| Chernett Jorey | 10% owner | 2026-03-27 | 500,000 | A | 9,393,276 |
| Chernett Jorey | 10% owner | 2026-03-26 | 25,000 | A | 8,893,276 |
| Chernett Jorey | 10% owner | 2026-03-25 | 125,000 | A | 8,868,276 |
| REUVERS DANIEL L. | President and CEO | 2026-03-23 | 1,500,000 | A | 1,500,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 2025-12-31 | 458,096 | 331,954 | 1.38 |
| Rockefeller Capital Management L.P. | 2025-12-31 | 2,070 | 1,500 | 1.38 |
| PEAK6 LLC | 2025-12-31 | 276,000 | 200,000 | 1.38 |
| Caitong International Asset Management Co., Ltd | 2025-12-31 | 96,263 | 69,756 | 1.38 |
| Aristides Capital LLC | 2025-12-31 | 188,232 | 136,400 | 1.38 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| Global X Funds | 2026-01-31 | Global X Russell 2000 ETF | RSSL | 16,703 | 34,909.27 | 0.0025 |
| ProFunds | 2026-01-31 | SMALL-CAP PROFUND SERVICE CLASS | SLPSX | 41 | 85.69 | 0.0011 |
| ProFunds | 2026-01-31 | SMALL-CAP PROFUND INVESTOR CLASS | SLPIX | 41 | 85.69 | 0.0011 |
| ProFunds | 2026-01-31 | ULTRASMALL-CAP PROFUND SERVICE CLASS | UAPSX | 503 | 1,051.27 | 0.002 |
| ProFunds | 2026-01-31 | ULTRASMALL-CAP PROFUND INVESTOR CLASS | UAPIX | 503 | 1,051.27 | 0.002 |